Adam Cheifetz, MD, Gastroenterology, Boston, MA, Beth Israel Deaconess Medical Center

AdamSCheifetzMD

Gastroenterology Boston, MA

Inflammatory Bowel Disease

Director, Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center; Professor of Medicine, Harvard Medical School

Dr. Cheifetz is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cheifetz's full profile

Already have an account?

Education & Training

  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineFellowship, Gastroenterology, 2003 - 2004
  • Yale-New Haven Hospital
    Yale-New Haven HospitalFellowship, Gastroenterology, 2001 - 2004
  • Yale-New Haven Hospital
    Yale-New Haven HospitalResidency, Internal Medicine, 1997 - 2000
  • Weill Cornell Medical College of Cornell University
    Weill Cornell Medical College of Cornell UniversityClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2023
  • CT State Medical License
    CT State Medical License 2000 - 2005
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Boston Magazine Castle Connolly, 2008-2013
  • Fellow (AGAF) American Gastroenterological Association, 2012
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease  
    Byron P Vaughn, Adam S Cheifetz, Digestive Diseases and Sciences

Lectures

  • Advances in Gastroenterology - 2013 
    Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 6/10/2013
  • Gastroenterology in the 21st Century: Optimizing Patient Outcomes 
    OMICS Publishing Group, Boston, Massachusetts - 5/7/2013

Other

Press Mentions

  • Therapeutic Drug Monitoring Not Ready for Prime Time in Rheumatology
    Therapeutic Drug Monitoring Not Ready for Prime Time in RheumatologyJanuary 22nd, 2020
  • IBDHorizons Announces First Annual Midwest Meeting, Focusing on IBD Education
    IBDHorizons Announces First Annual Midwest Meeting, Focusing on IBD EducationMarch 13th, 2018
  • Inflammatory Bowel Disease: Not Curable, but Treatable
    Inflammatory Bowel Disease: Not Curable, but TreatableApril 4th, 2016
  • Join now to see all

Professional Memberships

Hospital Affiliations